Discovery of Biomarkers for Tasmanian Devil Cancer (DFTD) by Metabolic Profiling of Serum
Version 2 2024-06-05, 00:50
Version 1 2016-10-07, 00:00
journal contribution
posted on 2024-06-05, 00:50 authored by N Karu, R Wilson, R Hamede, M Jones, GM Woods, EF Hilder, Robert ShellieDiscovery of Biomarkers for Tasmanian Devil Cancer (DFTD) by Metabolic Profiling of Serum
History
Related Materials
- 1.
Location
United StatesLanguage
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2016, American Chemical SocietyJournal
Journal of Proteome ResearchVolume
15Pagination
3827-3840ISSN
1535-3893eISSN
1535-3907Issue
10Publisher
AMER CHEMICAL SOCUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineBiochemical Research MethodsBiochemistry & Molecular BiologymetabolomicsserumTasmanian devilSarcophilus harrisiiDFTDcancerfibrinostatinFACIAL-TUMOR DISEASESARCOPHILUS-HARRISIIENVIRONMENTAL METABOLOMICSFUTURE PERSPECTIVESMASS-SPECTROMETRYCLASSIFICATIONTRANSMISSIONDIAGNOSISDATABASEHEALTHY3105 Genetics
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC